|
2024
|
Invention
|
Therapeutic methods and compositions for treating movement disorders.
The invention provides the... |
|
2020
|
Invention
|
Rna interference mediated inhibition of prolyl hydroxylase domain 2 (phd2) gene expression using ... |
|
2016
|
Invention
|
Tetragalnac containing conjugates and methods for delivery of oligonucleotides. Disclosed herein ... |
|
|
Invention
|
Diether based biodegradable cationic lipids for sirna delivery. Disclosed herein are novel cation... |
|
2013
|
Invention
|
Diester and triester based low molecular weight, biodegradeable cationic lipids for oligonucleoti... |
|
2010
|
Invention
|
Lipid nanoparticle based compositions and methods for the delivery of biologically active molecul... |
|
2004
|
Invention
|
Rna interference mediated inhibition of nogo and nogo receptor gene expression using short interf... |
|
|
Invention
|
Rna interference mediated inhibition of early growth response gene expression using short interfe... |
|
|
Invention
|
Rna interference mediated inhibition of protein tyrosine phosphatase type iva (prl3) gene express... |
|
|
Invention
|
Rna interference mediated inhibition of vascular endothelial growth factor and vascular endotheli... |
|
2003
|
Invention
|
Rna interference mediated inhibition of gene expression using chemically modified short interferi... |
